DEVELOPMENT OF BIOACTIVE NANOCOMPOSITES FOR BONE TISSUE ENGINEERING APPLICATIONS
Bone has a remarkable capacity to heal. However, in some instances the amount of bone which is needed to heal exceeds its healing capacity. These cases arise following accidents, infection or surgery to remove cancerous tissue and...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PIEZOSCAFF
Piezoelectric nanohybrid scaffolds for bone regeneration
50K€
Cerrado
CTQ2016-76721-R
NUEVAS ESTRUCTURAS 3D BASADAS EN NANOCOMPOSITES DE NANOMATER...
200K€
Cerrado
FIBROGELNET
Network for Development of Soft Nanofibrous Construct for Ce...
911K€
Cerrado
PhotoNanoBone
Photoresponsive Smart Nanocarriers for Tetherless Regenerati...
158K€
Cerrado
PTQ-08-03-07879
Desarrollo de un grupo de investigación en el area de la nan...
83K€
Cerrado
NANOREMEDI
Functional Nano-Scaffolds for Regenerative Medicine
3M€
Cerrado
Información proyecto NanoFact
Líder del proyecto
OFFALY COUNTY COUNCIL
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
371K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Bone has a remarkable capacity to heal. However, in some instances the amount of bone which is needed to heal exceeds its healing capacity. These cases arise following accidents, infection or surgery to remove cancerous tissue and they result in the need to perform approximately 600,000 surgical bone grafting procedures annually. These procedures have inherent disadvantages and so there is an urgent clinical need to develop a tissue engineering alternative to bone grafting.
In this study an osteoconductive/osteoinductive nanoscaffold will be designed to retain growth factors with proven osteogenic potential within their structure. As such, relatively low doses of these expensive molecules can be retained at the bone defect site. The technology developed in this study has enormous potential to reduce the overall burden placed on patients and on European healthcare systems by reducing the costs involved in using Growth Factors in a variety of applications. To perform this work the Fellow will move from Athlone Institute of Technology, Ireland to join a leading orthopaedic research group at one of Harvard University’s teaching hospitals where he will be trained in nanotoxicity testing, detection of growth factor release, cell loading and orthopaedic preclinical models. The Fellow has extensive knowledge in the field of biomaterials and orthopaedic research having trained at the AO Research Institute, Davos, Switzerland. However this fellowship will allow him to develop his knowledge in the field of biocompatibility testing. Knowledge developed in this area will be transferred back to Europe during the return phase of the fellowship. This knowledge will allow the Fellow to further refine the research carried out at Harvard. The goal of this research is to develop translational solutions to clinical problems. Indeed, the chance to work at Harvard would be hugely beneficial in developing direct links to clinicians at one of the world’s most prestigious Universities.